Kidney disease and cardiovascular risk could be better predicted with a simple blood test
A study led by the Institute of Cardiovascular and Medical Sciences, and published in Nature Medicine, has highlighted that a simple blood test is a better way of measuring both kidney and cardiovascular disease risk, as it offers a more precise diagnosis and could lead to better patient outcomes.
Chronic kidney disease characterised by gradual loss of kidney function over time is common, affecting around 10% of the population. It is also associated with premature cardiovascular disease and mortality and more rarely progresses to the point where patients need dialysis or a kidney transplant.
Dr Jennifer Lees, Institute of Cardiovascular and Medical Sciences, said: “Our findings indicate that patients would benefit from the added predictive value of using a test called the cystatin C test. We would hope to see it adopted as the primary method for diagnosis of chronic kidney disease – particularly for those patients with cardiovascular disease risk factors such as diabetes, hypertension or obesity.”
A link to the study can be found here.
First published: 6 December 2019